GlassScriptPhysician profile
Danielle I Kay
NPI 1811378748
$15,696.34
in general payments reported to CMS, 2019-2025
10 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.47 · 2020: $2,169 · 2021: $146 · 2022: $69.82 · 2023: $8,718 · 2024: $4,347 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,600.00 |
| Food and Beverage | $615.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,722.54 | 2020-2024 | Da Vinci Surgical System |
| Abbvie INC. | $213.90 | 2023-2025 | |
| Ethicon US, LLC | $191.91 | 2022-2023 | Vistaseal |
| Axonics, INC. | $149.73 | 2024 | Axonics |
| Medtronic, INC. | $145.75 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $86.72 | 2025 | |
| Baxter Healthcare | $82.53 | 2019 | |
| Tactile Systems Technology INC | $46.74 | 2020 | |
| Applied Medical Resources Corporation | $42.58 | 2025 | |
| W. L. Gore & Associates, INC. | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Kay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.